143 related articles for article (PubMed ID: 25811651)
1. Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents.
DeBono A; Capuano B; Scammells PJ
J Med Chem; 2015 Aug; 58(15):5699-727. PubMed ID: 25811651
[TBL] [Abstract][Full Text] [Related]
2. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents.
Debono AJ; Mistry SJ; Xie J; Muthiah D; Phillips J; Ventura S; Callaghan R; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2014 Feb; 9(2):399-410. PubMed ID: 24339417
[TBL] [Abstract][Full Text] [Related]
3. Noscapine comes of age.
Chen X; Dang TT; Facchini PJ
Phytochemistry; 2015 Mar; 111():7-13. PubMed ID: 25583437
[TBL] [Abstract][Full Text] [Related]
4. The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications.
Rida PC; LiVecche D; Ogden A; Zhou J; Aneja R
Med Res Rev; 2015 Sep; 35(5):1072-96. PubMed ID: 26179481
[TBL] [Abstract][Full Text] [Related]
5. Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro.
Yang ZR; Liu M; Peng XL; Lei XF; Zhang JX; Dong WG
Biochem Biophys Res Commun; 2012 May; 421(3):627-33. PubMed ID: 22546556
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of N-substituted noscapine analogues.
DeBono AJ; Xie JH; Ventura S; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2012 Dec; 7(12):2122-33. PubMed ID: 23055449
[TBL] [Abstract][Full Text] [Related]
7. A Papaver somniferum 10-gene cluster for synthesis of the anticancer alkaloid noscapine.
Winzer T; Gazda V; He Z; Kaminski F; Kern M; Larson TR; Li Y; Meade F; Teodor R; Vaistij FE; Walker C; Bowser TA; Graham IA
Science; 2012 Jun; 336(6089):1704-8. PubMed ID: 22653730
[TBL] [Abstract][Full Text] [Related]
8. A Novel Class of N-Sulfonyl and N-Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer Cells.
Yong C; Devine SM; Gao X; Yan A; Callaghan R; Capuano B; Scammells PJ
ChemMedChem; 2019 Dec; 14(23):1968-1981. PubMed ID: 31714012
[TBL] [Abstract][Full Text] [Related]
9. The anti-cancer activity of noscapine: a review.
Mahmoudian M; Rahimi-Moghaddam P
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):92-7. PubMed ID: 19149691
[TBL] [Abstract][Full Text] [Related]
10. Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics.
Lopus M; Naik PK
Pharmacol Rep; 2015 Feb; 67(1):56-62. PubMed ID: 25560576
[TBL] [Abstract][Full Text] [Related]
11. Induction of acetylation and bundling of cellular microtubules by 9-(4-vinylphenyl) noscapine elicits S-phase arrest in MDA-MB-231 cells.
Cheriyamundath S; Mahaddalkar T; Kantevari S; Lopus M
Biomed Pharmacother; 2017 Feb; 86():74-80. PubMed ID: 27939522
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.
Aneja R; Vangapandu SN; Lopus M; Chandra R; Panda D; Joshi HC
Mol Pharmacol; 2006 Jun; 69(6):1801-9. PubMed ID: 16517755
[TBL] [Abstract][Full Text] [Related]
13. Noscapine, a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.
Altinoz MA; Topcu G; Hacimuftuoglu A; Ozpinar A; Ozpinar A; Hacker E; Elmaci İ
Neurochem Res; 2019 Aug; 44(8):1796-1806. PubMed ID: 31292803
[TBL] [Abstract][Full Text] [Related]
14. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses.
Ke Y; Ye K; Grossniklaus HE; Archer DR; Joshi HC; Kapp JA
Cancer Immunol Immunother; 2000 Jul; 49(4-5):217-25. PubMed ID: 10941904
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel and improved antimitotic agents derived from noscapine.
Anderson JT; Ting AE; Boozer S; Brunden KR; Crumrine C; Danzig J; Dent T; Faga L; Harrington JJ; Hodnick WF; Murphy SM; Pawlowski G; Perry R; Raber A; Rundlett SE; Stricker-Krongrad A; Wang J; Bennani YL
J Med Chem; 2005 Nov; 48(23):7096-8. PubMed ID: 16279766
[TBL] [Abstract][Full Text] [Related]
17. Engineering biosynthesis of the anticancer alkaloid noscapine in yeast.
Li Y; Smolke CD
Nat Commun; 2016 Jul; 7():12137. PubMed ID: 27378283
[TBL] [Abstract][Full Text] [Related]
18. Discovery of S-phase arresting agents derived from noscapine.
Anderson JT; Ting AE; Boozer S; Brunden KR; Danzig J; Dent T; Harrington JJ; Murphy SM; Perry R; Raber A; Rundlett SE; Wang J; Wang N; Bennani YL
J Med Chem; 2005 Apr; 48(8):2756-8. PubMed ID: 15828811
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel anti-cancer agents by the synthesis and cellular screening of a noscapine-based library.
Nemati F; Bischoff-Kont I; Salehi P; Nejad-Ebrahimi S; Mohebbi M; Bararjanian M; Hadian N; Hassanpour Z; Jung Y; Schaerlaekens S; Lucena-Agell D; Oliva MA; Fürst R; Nasiri HR
Bioorg Chem; 2021 Oct; 115():105135. PubMed ID: 34303039
[TBL] [Abstract][Full Text] [Related]
20. CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism.
Yang Y; Ran J; Sun L; Sun X; Luo Y; Yan B; Tala ; Liu M; Li D; Zhang L; Bao G; Zhou J
Theranostics; 2015; 5(7):656-66. PubMed ID: 25897332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
